- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Synergy Pharmaceuticals Inc+ Add to Watchlist
SGYP:US5.9700 USD 0.1300 2.13%
As of 17:20:00 ET on 03/11/2014.
Company Profile for Synergy Pharmaceuticals Inc (SGYP)
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead drug candidate is a a guanylyl cyclase C (GC-C) receptor agonist, to treat gastrointestinal disorders, primarily chronic constipation and constipation-predominant irritable bowel syndrome (IBS-C).
Synergy Pharmaceuticals Inc
Key Executives for Synergy Pharmaceuticals Inc (SGYP)
|Gary S JacobPresident/CEO||Kunwar ShailubhaiChief Scientific Officer|
|Patrick H GriffinChief Medical Officer||Bernard F DenoyerSenior VP:Finance/Secretary|